In June 2024, The American Board of Internal Medicine has announced that it will introduce a new, modular version of its hematology Knowledge Assessment, beginning in 2021. This new and innovative approach will provide diplomats more flexibility and options used to demonstrate their knowledge and expertise in the field of hematology.
This new modular assessment consists two district companies that are Foundational Knowledge Assessment and a Specialty –Specific Knowledge assessment. The focus of Foundation Knowledge Assessment will delve deeper into specific areas of hematology, such as malignant hematology and classical hematology.
Diplomate are now able to choose their own assessment that aligns best with their practices and interests. The introduction of this new modular assessment format is a part of ABIM ongoing effort to provide more relevant, effective, and flexible assessment for its diplomates.
The new hemotalogy knowledge Assessment will be now available in addition to the existing general assessment of hematology. It provides the diplomate with more options to maintain their certification. ABIM’s introduction of this innovative assessment format demonstrates its ongoing commitment to support the ongoing professional development of internist and subspecialist. It also promote excellence in the field of patient care.
As per the Coherent Market Insights, the global hematology analyzer market is expected to reach at a CAGR of 7.3% between 2024 and 2031. In 2031, revenue is poised to reach at a total of US$ 8.07 Billion from US$ 4.94 Billion in 2024. Rising incidences of blood disorder and cancer will drive the demand in the global hematology market. Blood disorder is considered as a major challenge as the occurrence of blood disorder will continue to grow in upcoming years. The common types of blood disorder are coagulation disorder, blood cancer, anemia, and hemophilia.
Increasing number of patient who are suffering from the blood-related health issues has boost the market growth. The selection of right diagnosis will play an important role in timely and effective treatment of analyzers.
Moreover, increasing ageing population is the other factor that drive market growth. In the both developed and developing region the rate of aging population is high. This is due to the gain in the life expectancy rate and decline in the fertility level. People above the age of 65 years are the major consumers based who demand for frequent medical testing and monitoring services.
“Increasing adoption of automation in hermatology testing and technological advancement will drive growth in the global market”, says lead medical devices analyst Manisha Vibhute. Additionally, North America is poised to lead the way in the global hematology market by 2031. The region is accounted for 41.3% shares in the global market. This is due to the presence of well-established healthcare infrastructure in the developed country such as U.S.
Strong demand for advanced hematology testing will aid in rising incidence of blood disorder and cancer cases in the region. The region will adopt new technologies easily which help the market leader to launch and innovative new product quickly.
